

<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>

</head>

<body>

    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141640102006250%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201905008%26RESULT%3d1%26SIGN%3dKwa49K8MgkzAD7jgvJcZTpbcDXE%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201905008&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201905008&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>


    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201905008&amp;v=MDcxNjg2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVWJ6UFBUWE1aYkc0SDlqTXFvOUZiSVFLREg4NHZSNFQ=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#46" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#47" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#50" data-title="1.2 方法">1.2 方法</a></li>
                                                <li><a href="#53" data-title="1.3 统计学分析">1.3 统计学分析</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#55" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#56" data-title="2.1 HF组、健康组入院时血清sCD40L、NT-proBNP水平对比">2.1 HF组、健康组入院时血清sCD40L、NT-proBNP水平对比</a></li>
                                                <li><a href="#59" data-title="2.2 Ⅱ级组、Ⅲ级组治疗前后血清sCD40L、NT-proBNP水平对比">2.2 Ⅱ级组、Ⅲ级组治疗前后血清sCD40L、NT-proBNP水平对比</a></li>
                                                <li><a href="#62" data-title="2.3 主要不良心血管事件(MACE)发生率、MACE组与无MACE组血清sCD40L、NT-proBNP水平对比">2.3 主要不良心血管事件(MACE)发生率、MACE组与无MACE组血清sCD40L、NT-pro......</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#65" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#58" data-title="&lt;b&gt;表&lt;/b&gt;1 HF&lt;b&gt;组、健康组血清&lt;/b&gt;sCD40L、NT-proBNP&lt;b&gt;水平比较&lt;/b&gt;&lt;mathml id=&quot;71&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt;(&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo stretchy=&quot;false&quot;&gt;)&lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>1 HF<b>组、健康组血清</b>sCD40L、NT-proBNP<b>水平比较</b><mathml id="71"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">)</mo></mrow></math></mathml></a></li>
                                                <li><a href="#61" data-title="&lt;b&gt;表&lt;/b&gt;2 Ⅱ&lt;b&gt;级组、Ⅲ级组治疗前后血清&lt;/b&gt;sCD40L、NT-proBNP&lt;b&gt;水平对比分析&lt;/b&gt;&lt;mathml id=&quot;72&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt;(&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo stretchy=&quot;false&quot;&gt;)&lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>2 Ⅱ<b>级组、Ⅲ级组治疗前后血清</b>sCD40L、NT-proBNP<b>水平对比分析</b><mathml id="72"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">)</mo></mrow></math></mathml></a></li>
                                                <li><a href="#64" data-title="&lt;b&gt;表&lt;/b&gt;3 MACE&lt;b&gt;组、无&lt;/b&gt;MACE&lt;b&gt;组血清&lt;/b&gt;sCD40L、NT-proBNP&lt;b&gt;水平比较&lt;/b&gt;&lt;mathml id=&quot;73&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt;(&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo stretchy=&quot;false&quot;&gt;)&lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>3 MACE<b>组、无</b>MACE<b>组血清</b>sCD40L、NT-proBNP<b>水平比较</b><mathml id="73"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">)</mo></mrow></math></mathml></a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="李春伟,李轶鹏,秦文艳,等.血清sCD40L联合NT-proBNP对心力衰竭的诊断及预后评估价值研究[J].中国实验诊断学,2017,21(5):816-819." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZSZD201705016&amp;v=MDgxNTBabUZ5bmhVYnpQUHo3UmFyRzRIOWJNcW85RVlvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnU=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        李春伟,李轶鹏,秦文艳,等.血清sCD40L联合NT-proBNP对心力衰竭的诊断及预后评估价值研究[J].中国实验诊断学,2017,21(5):816-819.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="Luo NS,Zhang HF,Liu PM,et al.Diagnostic value of combining serum soluble ST2 and interleukin-33 for heart failure patients with preserved left ventricular ejection fraction.[J].Zhonghua Xin Xue Guan Bing Za Zhi,2017,45(3):198-203." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Diagnostic value of combining serum soluble ST2and interleukin-33 for heart failure patients with preserved left ventricular ejection fraction">
                                        <b>[2]</b>
                                        Luo NS,Zhang HF,Liu PM,et al.Diagnostic value of combining serum soluble ST2 and interleukin-33 for heart failure patients with preserved left ventricular ejection fraction.[J].Zhonghua Xin Xue Guan Bing Za Zhi,2017,45(3):198-203.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title="刘子源,刘帅,张艳丽,等.sST2、NT-proBNP及sCD40L在急性冠脉综合征危险分层及预后评估中的临床意义[J].中西医结合心脑血管病杂志,2016,14(2):180-182." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYYY201602026&amp;v=MDUyNjJDVVI3cWZadVptRnluaFVielBQelRTZDdHNEg5Zk1yWTlIWW9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnI=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        刘子源,刘帅,张艳丽,等.sST2、NT-proBNP及sCD40L在急性冠脉综合征危险分层及预后评估中的临床意义[J].中西医结合心脑血管病杂志,2016,14(2):180-182.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="朱桢燕,孙建辉,柯海燕.血清胱抑素C与慢性心力衰竭的关系及临床意义[J].中国心血管病研究,2015,13(5):410-413." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGZ201505011&amp;v=MDc1OTVxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhVYnpQUFRYTWRMRzRIOVRNcW85RVpZUUtESDg0dlI0VDZqNTRPM3o=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                        朱桢燕,孙建辉,柯海燕.血清胱抑素C与慢性心力衰竭的关系及临床意义[J].中国心血管病研究,2015,13(5):410-413.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="Scrutinio D,Guida P,Ammirati E,et al.Long-term prognostic implications of the ADHF/NT-proBNP risk score in patients admitted with advanced heart failure [J].J Heart Lung transplant,2016,35(10):1264-1267." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Long-term prognostic implications of the ADHF/NT-pro BNP risk score in patients admitted with advanced heart failure">
                                        <b>[5]</b>
                                        Scrutinio D,Guida P,Ammirati E,et al.Long-term prognostic implications of the ADHF/NT-proBNP risk score in patients admitted with advanced heart failure [J].J Heart Lung transplant,2016,35(10):1264-1267.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title="Cerasela MG,Florin PA,Daniel CL,et al.Serum level of apelin-13 negatively correlated with NT-proBNP in heart failure patients[J].Revista Rom&#226;n de Medicin de Laborator,2016,24(4):399-412." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Serum level of apelin-13 negatively correlated with NT-proBNP in heart failure patients">
                                        <b>[6]</b>
                                        Cerasela MG,Florin PA,Daniel CL,et al.Serum level of apelin-13 negatively correlated with NT-proBNP in heart failure patients[J].Revista Rom&#226;n de Medicin de Laborator,2016,24(4):399-412.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" title="曾雪,方小丽,何扬利.血清25-(OH)D3、hsCRP及NT-proBNP与慢性心衰患者心衰程度及预后的关系[J].心血管康复医学杂志,2016,25(4):394-398." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201604014&amp;v=MjE2ODY0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhVYnpQUFRYTVpiRzRIOWZNcTQ5RVlJUUtESDg0dlI=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[7]</b>
                                        曾雪,方小丽,何扬利.血清25-(OH)D3、hsCRP及NT-proBNP与慢性心衰患者心衰程度及预后的关系[J].心血管康复医学杂志,2016,25(4):394-398.
                                    </a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="杨雯婷.IMA、hsCRP、NT-proBNP及sCD40L指标在急性冠脉综合征早期诊断价值研究[J].中国实验诊断学,2016,20(12):2034-2037." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZSZD201612017&amp;v=MjQ1NDI3UmFyRzRIOWZOclk5RVk0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhVYnpQUHo=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                        杨雯婷.IMA、hsCRP、NT-proBNP及sCD40L指标在急性冠脉综合征早期诊断价值研究[J].中国实验诊断学,2016,20(12):2034-2037.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" title="陈建,华琦.心力衰竭的诊断与治疗[M].北京:人民卫生出版社,2006." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CBBD&amp;filename=0007117080329001&amp;v=MzA1MjlWMjdHYks1R2RIRXI0eEhiZXNQRFJNOHp4VVNtRGQ5U0g3bjN4RTlmYnZuS3JpZlplWnZGeW50VTc3TUlsMFRW&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                        陈建,华琦.心力衰竭的诊断与治疗[M].北京:人民卫生出版社,2006.
                                    </a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="Hiroki N,Koichi F,Minoru T,et al.The response of NT-proBNP to intensified medication in advanced chronic heart failure [J].IJC Metabolic &amp;amp; Endocrine,2016,10:24-29." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJESB3DD36CF5187F242E5946C8EE10CBD11&amp;v=MjY5OTUwZWNIbU1idWVDT052RlNpV1dyN0pJRnBtYUJ1SFlmT0dRbGZCckxVMDV0Qmh4Ynk5dzY4PU5pZk9mY0c3YXFYUHFmd3pZZW9IQ3dvN3l4Um03elo1VGd6cTJXYw==&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        Hiroki N,Koichi F,Minoru T,et al.The response of NT-proBNP to intensified medication in advanced chronic heart failure [J].IJC Metabolic &amp;amp; Endocrine,2016,10:24-29.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="Besli F,Gullulu S,Sag S,et al.The relationship between serum lectin-like oxidized LDL receptor-1 levels and systolic heart failure[J].Acta Cardiol,2016,71(2):185-190." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=STJD&amp;filename=STJDE70864F413D730D244187FA99E9B12C7&amp;v=MDAyNTB1SFlmT0dRbGZCckxVMDV0Qmh4Ynk5dzY4PU5qbkJhc2EvSHRuS3EvbEJaZWg3QzM4NXV4UVg3ajUxVHdtVHBSdEFjTUNWUjhtWUNPTnZGU2lXV3I3SklGcG1hQg==&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        Besli F,Gullulu S,Sag S,et al.The relationship between serum lectin-like oxidized LDL receptor-1 levels and systolic heart failure[J].Acta Cardiol,2016,71(2):185-190.
                                    </a>
                                </li>
                                <li id="27">


                                    <a id="bibliography_12" title="金德奎,於四军,王文启,等.静息心率与慢性心力衰竭患者血清NT-proBNP的相关性分析[J].现代生物医学进展,2016,16(18):3519-3522." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SWCX201618030&amp;v=MjcyNjY0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhVYnpQTmpySWRyRzRIOWZOcDQ5R1pJUUtESDg0dlI=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                        金德奎,於四军,王文启,等.静息心率与慢性心力衰竭患者血清NT-proBNP的相关性分析[J].现代生物医学进展,2016,16(18):3519-3522.
                                    </a>
                                </li>
                                <li id="29">


                                    <a id="bibliography_13" title="宋伟,黄国勇,方勇,等.血清N-端脑钠肽前体在慢性心力衰竭预后评价中的应用价值分析[J].中国循证心血管医学杂志,2016,8(12):1501-1503." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PZXX201612031&amp;v=MjgyMjdUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnluaFVielBOVGZUZHJHNEg5Zk5yWTlHWllRS0RIODR2UjQ=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                        宋伟,黄国勇,方勇,等.血清N-端脑钠肽前体在慢性心力衰竭预后评价中的应用价值分析[J].中国循证心血管医学杂志,2016,8(12):1501-1503.
                                    </a>
                                </li>
                                <li id="31">


                                    <a id="bibliography_14" title="Heng Q.GW26-e2439 Based on clinical studies of plasma NT-proBNP for the diagnosis of diastolic heart failure optimal cutoff value observed[J].Journal of the American College of Cardiology,2015,66(16):C210-C211." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJESDDFDE00F5E75ED3FEDA3601239E7D2EC&amp;v=Mjg2Mzltbms1K1RuL2pyaEU4RExYZ1I4L3NDT052RlNpV1dyN0pJRnBtYUJ1SFlmT0dRbGZCckxVMDV0Qmh4Ynk5dzY4PU5pZk9mY2ZNYUtXNXI0OHpZWjRJQ1FsTnpHQg==&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[14]</b>
                                        Heng Q.GW26-e2439 Based on clinical studies of plasma NT-proBNP for the diagnosis of diastolic heart failure optimal cutoff value observed[J].Journal of the American College of Cardiology,2015,66(16):C210-C211.
                                    </a>
                                </li>
                                <li id="33">


                                    <a id="bibliography_15" title="Mehrdad S,Ali RB,Mehrzad R,et al.N-terminal pro-beta-type natriuretic peptide (NT-proBNP) can be considered a valuable predictor of heart rejection[J].Indian Journal of Thoracic &amp;amp; Cardiovascular Surgery,2015,31(4):1-5." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=N-terminal pro-beta-type natriuretic peptide (NT-proBNP) can be considered a valuable predictor of heart rejection">
                                        <b>[15]</b>
                                        Mehrdad S,Ali RB,Mehrzad R,et al.N-terminal pro-beta-type natriuretic peptide (NT-proBNP) can be considered a valuable predictor of heart rejection[J].Indian Journal of Thoracic &amp;amp; Cardiovascular Surgery,2015,31(4):1-5.
                                    </a>
                                </li>
                                <li id="35">


                                    <a id="bibliography_16" title="林绍侠,刘志兵,蔡铁海,等.血清sST2联合NT-proBNP检测对心力衰竭患者预后的预测价值[J].山东医药,2016,56(26):61-62." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SDYY201626024&amp;v=MDY4MTJPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhVYnpQTmluU2Q3RzRIOWZPcVk5SFlJUUtESDg0dlI0VDZqNTQ=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[16]</b>
                                        林绍侠,刘志兵,蔡铁海,等.血清sST2联合NT-proBNP检测对心力衰竭患者预后的预测价值[J].山东医药,2016,56(26):61-62.
                                    </a>
                                </li>
                                <li id="37">


                                    <a id="bibliography_17" title="李曼,温冬梅,王伟佳,等.NT-proBNP水平对急性心力衰竭患者近期预后的评估价值[J].检验医学与临床,2017,14(12):1720-1722,1725." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=JYYL201712015&amp;v=MTg3MjVyRzRIOWJOclk5RVlZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhVYnpQTHpUU1k=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[17]</b>
                                        李曼,温冬梅,王伟佳,等.NT-proBNP水平对急性心力衰竭患者近期预后的评估价值[J].检验医学与临床,2017,14(12):1720-1722,1725.
                                    </a>
                                </li>
                                <li id="39">


                                    <a id="bibliography_18" title="Passeri E,Rigolini R,Costa E,et al.Serum NT-proBNP Levels Are Not Related to Vitamin D Status in Young Patients with Congenital Heart Defects[J].Dis Markers,2016,2016." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJHD&amp;filename=SJHDF68522678B755B915B78F7FF6C68DF98&amp;v=MTQ1OTFXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhieTl3Njg9TmlmRGFzVytGdFRPcllsQ2JKa0lDWGxMeGhjV21EaDFQbmlVMmhSR2Y3cmdNN09YQ09OdkZTaQ==&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[18]</b>
                                        Passeri E,Rigolini R,Costa E,et al.Serum NT-proBNP Levels Are Not Related to Vitamin D Status in Young Patients with Congenital Heart Defects[J].Dis Markers,2016,2016.
                                    </a>
                                </li>
                                <li id="41">


                                    <a id="bibliography_19" title="徐正云,任国珍.老年心力衰竭合并心房颤动病人血清NT-proBNP的临床意义[J].中西医结合心脑血管病杂志,2017,15(17):2157-2160." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYYY201717068&amp;v=MDgxOTJPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhVYnpQUHpUU2Q3RzRIOWJOcUk5RGJJUUtESDg0dlI0VDZqNTQ=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[19]</b>
                                        徐正云,任国珍.老年心力衰竭合并心房颤动病人血清NT-proBNP的临床意义[J].中西医结合心脑血管病杂志,2017,15(17):2157-2160.
                                    </a>
                                </li>
                                <li id="43">


                                    <a id="bibliography_20" title="Riphagen IJ,Logtenberg SJ,Groenier KH,et al.Is the association of serum sodium with mortality in patients with type 2 diabetes explained by copeptin or NT-proBNP?(ZODIAC-46).[J].Atherosclerosis,2015,242(1):179-185." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15120900225723&amp;v=MDMyMDBmYks5SDlQTXBvOUZadWtLQzM0Nm9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlWb1dhUlU9TmlmTw==&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[20]</b>
                                        Riphagen IJ,Logtenberg SJ,Groenier KH,et al.Is the association of serum sodium with mortality in patients with type 2 diabetes explained by copeptin or NT-proBNP?(ZODIAC-46).[J].Atherosclerosis,2015,242(1):179-185.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(05),590-594 DOI:10.3969/j.issn.1008-0074.2019.05.08            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>血清</b>sCD40L、NT-proBNP<b>水平检测对老年心力衰竭早期诊断及预后评估的价值</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%BD%AD%E6%87%BF&amp;code=31314288&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">彭懿</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E9%99%88%E9%A2%96%E6%99%96&amp;code=21221192&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">陈颖晖</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%90%B4%E9%9D%99%E6%96%87&amp;code=43039613&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">吴静文</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E4%B8%AD%E5%9B%BD%E5%BB%BA%E7%AD%91%E7%AC%AC%E4%B8%89%E5%B7%A5%E7%A8%8B%E5%B1%80%E6%AD%A6%E6%B1%89%E4%B8%AD%E5%BF%83%E5%8C%BB%E9%99%A2%E6%80%A5%E8%AF%8A%E7%A7%91&amp;code=0102926&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">中国建筑第三工程局武汉中心医院急诊科</a>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E4%B8%AD%E5%9B%BD%E5%BB%BA%E7%AD%91%E7%AC%AC%E4%B8%89%E5%B7%A5%E7%A8%8B%E5%B1%80%E6%AD%A6%E6%B1%89%E4%B8%AD%E5%BF%83%E5%8C%BB%E9%99%A2%E5%BF%83%E5%86%85%E7%A7%91&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">中国建筑第三工程局武汉中心医院心内科</a>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E4%B8%AD%E5%9B%BD%E5%BB%BA%E7%AD%91%E7%AC%AC%E4%B8%89%E5%B7%A5%E7%A8%8B%E5%B1%80%E6%AD%A6%E6%B1%89%E4%B8%AD%E5%BF%83%E5%8C%BB%E9%99%A2%E6%A3%80%E9%AA%8C%E7%A7%91&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">中国建筑第三工程局武汉中心医院检验科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:研究血清sCD40L、NT-proBNP水平检测对老年心力衰竭(HF)早期诊断及预后评估的价值。<b>方法</b>:选择2015年2月～2017年2月我院收治的老年HF患者73例为HF组,根据NYHA心功能分级将HF组分为Ⅱ级组(37例)和Ⅲ级组(36例);选择同期体检健康者112例作为健康组。HF组治疗1个月。随访1个月内主要心血管不良事件(MACE)发生率,根据随访期间是否发生MACE将HF组分为MACE组(20例)与无MACE组(53例),对比HF组治疗前与健康组;心功能Ⅱ级组与Ⅲ级组治疗前后;MACE组与无MACE组血清sCD40L、NT-proBNP水平。<b>结果</b>:HF组治疗前血清sCD40L、NT-proBNP水平均显著高于健康组(<i>P</i>均=0.001)。与治疗前相比,治疗后,Ⅱ级组与Ⅲ级组血清sCD40L、NT-proBNP水平均显著下降(<i>P</i>均=0.001)。与Ⅲ级组相比,Ⅱ级组治疗后血清sCD40L [(8.31±0.76) ng/ml比(7.37±0.81) ng/ml]水平降低更显著(<i>P</i>=0.001)。随访期间,HF组(73例)发生20例MACE,发生率为27.40%,无MACE组血清sCD40L [(10.26±1.54) ng/ml比(11.49±1.81) ng/ml]、NT-proBNP [(612.28±122.76) ng/L比(1072.25±245.68) ng/L]水平显著低于MACE组(<i>P</i>均=0.001)。<b>结论</b>:血清sCD40L、NT-proBNP水平检测对老年人HF早期诊断及预后评估有良好的应用价值,值得推广。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E5%8A%9B%E8%A1%B0%E7%AB%AD&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心力衰竭;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E8%80%81%E5%B9%B4%E4%BA%BA&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">老年人;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E8%AF%8A%E6%96%AD&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">诊断;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                                            </p>
                                    <p><b>收稿日期：</b>2018-06-12</p>

            </div>
                    <h1>Value of early diagnosis and prognosis assessment of serum sCD40L and NT-proBNP levels detection in aged patients with heart failure</h1>
                    <h2>
                    <span>PENG Yi</span>
                    <span>CHEN Ying-hui</span>
                    <span>WU Jing-wen</span>
            </h2>
                    <h2>
                    <span>Department of Emergency,Central Hospital of China Construction Third Engineering Bureau of Wuhan City</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>: To study application value of serum sCD40 L and NT-proBNP levels detection in early diagnosis and prognosis assessment of aged patients with heart failure(HF). <b>Methods</b>: A total of 73 aged HF patients treated in our hospital from Feb 2015 to Feb 2017 were selected as HF group. According to NYHA cardiac function class, HF group was divided into class Ⅱ group(n=37) and class Ⅲ group(n=36). A total of 112 healthy people, who had a physical examination in our hospital at the corresponding period, were selected as health group. HF group were treated for one month. Incidence of major adverse cardiovascular events(MACE) within one-month was recorded. According to MACE during one-month follow-up, HF group was divided into MACE group(n=20) and no MACE group(n=53). Serum levels of sCD40 L and NT-proBNP were measured and compared between HF group before treatment and health group; class Ⅱ group and class Ⅲ group before and after treatment; MACE group and no MACE group.<b>Results</b>: There were significant rise in serum levels of sCD40 L and NT-proBNP in HF group before treatment compared with health group, <i>P</i>=0.001 all. Compared with before treatment, there were significant reductions in serum levels of sCD40 L and NT-proBNP in class Ⅱ group and class Ⅲ group, <i>P</i>=0.001 all. After treatment, compared with class Ⅲ group there was significant reduction in serum level of sCD40 L[(8.31±0.76) ng/ml vs.(7.37±0.81) ng/ml] in class Ⅱ group, <i>P</i>=0.001. During one-month follow-up, 20 cases of MACE occurred in HF group(n=73) and incidence of MACE in HF group was 27.40%. Compared with MACE group, there were significant reductions in serum levels of sCD40 L [(10.26±1.54) ng/ml vs.(11.49±1.81) ng/ml] and NT-proBNP [(612.28±122.76) ng/L vs.(1072.25±245.68) ng/L] in no MACE group, <i>P</i>=0.001 all. <b>Conclusion</b>: Serum sCD40 L and NT-proBNP levels detection possesses good application value in early diagnosis and prognosis assessment for aged patients with HF, which is worth extending.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Heart%20failure&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Heart failure;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Aged&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Aged;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Trimetazidine&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Trimetazidine;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                                            </p>
                                    <p><b>Received：</b> 2018-06-12</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="45">心力衰竭(HF)是心血管内科常见疾病,也是导致死亡的重要原因之一,且一般预后效果较差<citation id="74" type="reference"><link href="5" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>,老年人是本病的高危人群。相关文献<citation id="80" type="reference"><link href="7" rel="bibliography" /><link href="9" rel="bibliography" /><sup>[<a class="sup">2</a>,<a class="sup">3</a>]</sup></citation>统计显示,一般人群中HF发生率为1.0%～2.0%,年龄65岁以上人群中HF患病率高达10%, HF不仅给患者的生活及工作造成严重影响,还给患者家庭,乃至社会带来沉重的经济负担。故早期明确诊断,并及时给予有效措施,可有效提高患者预后<citation id="75" type="reference"><link href="9" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>。研究<citation id="76" type="reference"><link href="11" rel="bibliography" /><sup>[<a class="sup">4</a>]</sup></citation>表示,HF临床治疗的关键是及时通过相关检查明确HF程度,进一步制定治疗方案。临床一般通过彩色多普勒超声检查、磁共振及电子计算机断层扫描(CT)等辅助检查判定心功能状况。但上述检查均对患者配合度要求较高,且费时费力,影响判断结果<citation id="77" type="reference"><link href="13" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>。近几年多项研究<citation id="81" type="reference"><link href="5" rel="bibliography" /><link href="15" rel="bibliography" /><sup>[<a class="sup">1</a>,<a class="sup">6</a>]</sup></citation>开始致力于研究心肌细胞标志物检测在HF诊断及预后评估中的应用价值。N末端B型钠尿肽前体(NT-proBNP)来自心脏受损后产生的BNP前体,BNP前体被酶分解为BNP和NT-proBNP,前者具有一定生物活性,半衰期较短,难以监测;而后者物生物活性强,半衰期较长,易于监测,故有利于早期诊断。可溶性白细胞分化抗原40配体(sCD40L)是肿瘤坏死因子超家族成员之一,在血管内皮细胞及B淋巴细胞中表达,在正常生理情况下几乎不表达,其和CD40结合可生成大量心血管疾病相关因子<citation id="78" type="reference"><link href="17" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>。研究<citation id="79" type="reference"><link href="19" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>表明,血清sCD40L、NT-proBNP水平是老年HF的早期预测指标。但目前关于血清sCD40L水平在HF程度评估中的应用价值的研究较少,鉴于此,本研究特探讨血清sCD40L、NT-proBNP水平与老年人HF程度的关系,也为老年HF诊断及病情评估提供参考,详细报告如下。</p>
                </div>
                <h3 id="46" name="46" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="47" name="47">1.1 一般资料</h4>
                <div class="p1">
                    <p id="48">选择我院2015年2月～2017年2月期间收治入院的老年HF患者73例作为HF组,纳入标准:符合中华医学会制定的HF相关诊断标准<citation id="82" type="reference"><link href="21" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>;经彩色多普勒超声检查确诊;纽约心脏病学会(NYHA)心功能分级II～IV级;患者自愿参与研究,家属知情同意,并签署知情同意书。排除标准:不符合纳入标准者;合并肺动脉栓塞者;严重肝、肾及肺功能障碍者;免疫系统功能障碍者;恶性肿瘤患者;伴发严重精神疾病及家族史和不配合研究者。本研究经院内医学伦理委员会审核通过。</p>
                </div>
                <div class="p1">
                    <p id="49">73例老年HF患者根据HF程度判定标准<citation id="83" type="reference"><link href="21" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>分为2组,其中II级组37例,男性19例,女性18例,年龄60～81(68.35±8.12)岁;III级组36例,男性17例,女性19例,年龄62～85(69.05±8.16)岁。各组间性别、年龄一般资料经统计学分析差异无统计学意义(<i>P</i>&gt;0.05),有可比性。选择同期在院体检的健康人群112例作为健康组,纳入标准:非HF患者;病例资料完整,自愿参与本次研究。其中,男58例,女54例,年龄62～83(69.47±9.05)岁。</p>
                </div>
                <h4 class="anchor-tag" id="50" name="50">1.2 方法</h4>
                <div class="p1">
                    <p id="51">受试者入院后均在晨起后采集肘静脉空腹血液标本3ml,放置于抗凝试管中,以1300r/min充分离心3min,然后取上层血清,放置在-70℃环境中保存待检。血清NT-proBNP、sCD40L水平检测采用ELISA法,试剂盒采用北京乐普医药有限公司提供的全自动分析仪,操作严格按照试剂盒中相关说明书进行。</p>
                </div>
                <div class="p1">
                    <p id="52">患者入院后主张多休息,适当限制体力活动,提倡清淡、易消化及低热量和低胆固醇食物。药物治疗:地高辛片(生产厂家:上海上药信谊药厂有限公司,国药准字H31020678)0.125～0.50mg,1次/d,;呋塞米(生产厂家:江苏亚邦爱普药业有限公司,国药准字H32021428)起始剂量20mg/d,1次/d,根据患者病情适当在6～8h后增加剂量至40mg/d,1次/d,直至利尿效果满意为止;结合患者心率及血压情况予以酒石酸美托洛尔片(阿斯利康制药有限公司,国药准字1710A11),剂量根据患者病情选择范围在12～50mg,2～3次/d,3次/d,;马来酸依那普利(石药集团欧意药业有限公司,国药准字133161001) 首次剂量2.5mg,1～2次/d,往后逐渐增加至5～20mg,2次/d,用药后注意血压变化。治疗1个月后进行随访,并再次检测患者HF组与健康组血清NT-proBNP水平及sCD40L水平。</p>
                </div>
                <h4 class="anchor-tag" id="53" name="53">1.3 统计学分析</h4>
                <div class="p1">
                    <p id="54">数据的统计处理采用软件SPSS 19.0。计量资料以均数±标准差<mathml id="70"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">)</mo></mrow></math></mathml>表示,比较采用<i>t</i>检验,计数资料以百分率表示,比较采用<i>χ</i><sup>2</sup>检验。<i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <h3 id="55" name="55" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="56" name="56">2.1 HF组、健康组入院时血清sCD40L、NT-proBNP水平对比</h4>
                <div class="p1">
                    <p id="57">治疗前,HF组血清sCD40L、NT-proBNP水平均显著高于健康组(<i>P</i>均=0.001)。见表1。</p>
                </div>
                <div class="area_img" id="58">
                    <p class="img_tit"><b>表</b>1 HF<b>组、健康组血清</b>sCD40L、NT-proBNP<b>水平比较</b><mathml id="71"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">)</mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="58" border="1"><tr><td><br />组别</td><td>例数</td><td>sCD40L<br />(ng/ml)</td><td>NT-proBNP<br />(ng/L)</td></tr><tr><td><br />HF组</td><td>73</td><td>11.46±1.27<sup>△△</sup></td><td>682.75±216.75<sup>△△</sup></td></tr><tr><td><br />健康组</td><td>112</td><td>7.35±0.94</td><td>59.45±23.45</td></tr><tr><td><br /><i>t</i></td><td></td><td>27.529</td><td>30.257</td></tr><tr><td><br /><i>P</i></td><td></td><td>0.001</td><td>0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:sCD40L:可溶性白细胞分化抗原40配体,NT-proBNP:N末端B型钠尿肽。下表同。与健康组比较△<i>P</i>&lt;0.05,△△<i>P</i>&lt;0.01。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="59" name="59">2.2 Ⅱ级组、Ⅲ级组治疗前后血清sCD40L、NT-proBNP水平对比</h4>
                <div class="p1">
                    <p id="60">治疗前,两组血清sCD40L水平差异无统计学意义(<i>P</i>&gt;0.05),Ⅲ 级组血清NT-proBNP水平显著高于Ⅱ级组(<i>P</i>=0.001)。治疗后,两组血清sCD40L、NT-proBNP水平均较治疗前显著下降,且Ⅱ级组血清sCD40L水平显著低于Ⅲ级组(<i>P</i>均=0.001)。见表2。</p>
                </div>
                <div class="area_img" id="61">
                                            <p class="img_tit">
                                                <b>表</b>2 Ⅱ<b>级组、Ⅲ级组治疗前后血清</b>sCD40L、NT-proBNP<b>水平对比分析</b><mathml id="72"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">)</mo></mrow></math></mathml>
                                                
                                                &nbsp;&nbsp;
                                                <a class="btn-zoomin" href="Detail/GetImg?filename=images/XXGK201905008_06100.jpg&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!"></a>
                                                <a class="table downimg" data-tablename="Detail/GetImg?filename=images/XXGK201905008_06100.jpg&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">下载原表</a>
                                            </p>
                                    <a class="zoom-in" href="Detail/GetImg?filename=images/XXGK201905008_06100.jpg&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <img alt="表2 Ⅱ级组、Ⅲ级组治疗前后血清sCD40L、NT-proBNP水平对比分析" src="Detail/GetImg?filename=images/XXGK201905008_06100.jpg&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
                                    </a>
                                <p class="img_note">注:与治疗前比较*<i>P</i>&lt;0.05,**<i>P</i>&lt;0.01;与Ⅱ级组比较△<i>P</i>&lt;0.05,△△<i>P</i>&lt;0.01。</p>

                </div>
                <h4 class="anchor-tag" id="62" name="62">2.3 主要不良心血管事件(MACE)发生率、MACE组与无MACE组血清sCD40L、NT-proBNP水平对比</h4>
                <div class="p1">
                    <p id="63">随访期间,HF组(73例)发生20例MACE,发生率为27.40%。根据随访期间是否发生MACE将HF组分为MACE组(20例)和无MACE组(53例)。无MACE组血清sCD40L、NT-proBNP水平均显著低于MACE组(<i>P</i>均=0.001)。见表3。</p>
                </div>
                <div class="area_img" id="64">
                    <p class="img_tit"><b>表</b>3 MACE<b>组、无</b>MACE<b>组血清</b>sCD40L、NT-proBNP<b>水平比较</b><mathml id="73"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">)</mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="64" border="1"><tr><td><br />组别</td><td>例数</td><td>sCD40L<br />(ng/ml)</td><td>NT-proBNP<br />(ng/ml)</td></tr><tr><td><br />MACE组</td><td>20</td><td>11.49±1.81<sup>△△</sup></td><td>1072.25±245.68<sup>△△</sup></td></tr><tr><td><br />无MACE组</td><td>53</td><td>10.26±1.54</td><td>612.28±122.76</td></tr><tr><td><br /><i>t</i></td><td></td><td>3.382</td><td>12.832</td></tr><tr><td><br /><i>P</i></td><td></td><td>0.001</td><td>0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:MACE:主要不良心血管事件。与无MACE组比较△<i>P</i>&lt;0.05,△△<i>P</i>&lt;0.01。</p>
                    <p class="img_note"></p>
                </div>
                <h3 id="65" name="65" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="66">HF指的是心血管疾病发展至一定程度引起心肌收缩力减弱以及心肌舒张功能障碍和心排出量减少,难以满足机体组织及细胞代谢所需能量,造成神经体液及血流动力学水平改变,继而出现一系列临床症状及体征<citation id="84" type="reference"><link href="23" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>。心脏肥厚、心肌纤维化及坏死凋亡是本病主要表现,心室的重构也会加重心功能恶化。研究<citation id="85" type="reference"><link href="19" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>发现某些血清标志物在HF早期筛查、诊断及预后评估中有一定临床价值。</p>
                </div>
                <div class="p1">
                    <p id="67">NT-proBNP是BNP前体在血液中分解产生的一种无生物学活性的物质,其半衰期为1～2h,临床中可追踪时间长达24h,故研究<citation id="86" type="reference"><link href="25" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>将其用于HF早期预测。脑肽素是一种心脏神经激素,其具有一定拮抗交感神经系统及肾素-血管紧张素-醛固酮系统的作用,同时还有扩血管、利尿及促进钠离子排出等多种作用;研究<citation id="87" type="reference"><link href="27" rel="bibliography" /><sup>[<a class="sup">12</a>]</sup></citation>证实其还可调控机体血压,抑制水钠出溜,继而改善肺循环,降低血管外周阻力。目前NT-proBNP临床应用较为广泛,宋伟等<citation id="88" type="reference"><link href="29" rel="bibliography" /><sup>[<a class="sup">13</a>]</sup></citation>证实,血清NT-proBNP水平和HF程度呈一定正相关性,故认为其可作为HF病情评估的指标。国外研究<citation id="89" type="reference"><link href="31" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>表明,NT-proBNP还可有效评定HF预后情况。上述研究均可初步判定血清NT-proBNP水平检测在HF患者临床诊断、病情评估及预后评定等方面具有重要价值。本次研究结果显示,治疗前,HF组血清NT-proBNP水平显著高于健康组(<i>P</i>均=0.001)。在HF组中,Ⅲ 级组治疗前后血清NT-proBNP水平均显著高于Ⅱ级组(<i>P</i>均=0.001),在该结果和国内外诸多学者<citation id="91" type="reference"><link href="7" rel="bibliography" /><link href="33" rel="bibliography" /><sup>[<a class="sup">2</a>,<a class="sup">15</a>]</sup></citation>研究结果一致。国外学者<citation id="90" type="reference"><link href="35" rel="bibliography" /><sup>[<a class="sup">16</a>]</sup></citation>也证实血清 NT-proBNP水平是反映心室功能的一个重要特异性指标,其可在一定程度上反映左心室舒张末压情况,并且研究还证实其和心功能分级存在一定相关性。且多项研究<citation id="92" type="reference"><link href="35" rel="bibliography" /><link href="37" rel="bibliography" /><sup>[<a class="sup">16</a>,<a class="sup">17</a>]</sup></citation>证实血清NT-proBNP水平可独立预测HF患者舒张功能情况。</p>
                </div>
                <div class="p1">
                    <p id="68">CD40L作为一种肿瘤坏死因子超家族跨膜蛋白,在正常的动脉中几乎零表达,只有发生心血管疾病时, CD40L才会在巨噬细胞及血管内皮细胞中不同程度地表达<citation id="93" type="reference"><link href="25" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>。sCD40L是CD40L裂解生成的一种物质,血清sCD40L水平升高可促进血小板活化聚集,研究<citation id="94" type="reference"><link href="29" rel="bibliography" /><sup>[<a class="sup">13</a>]</sup></citation>证实sCD40L在血栓形成以及炎症反应中均发挥重要作用。本次结果中HF组治疗前血清sCD40L水平显著高于健康组(<i>P</i>=0.001),该结果和Passeri E等人研究<citation id="95" type="reference"><link href="39" rel="bibliography" /><sup>[<a class="sup">18</a>]</sup></citation>结果一致。治疗前,Ⅱ级组、Ⅲ级组血清sCD40L水平差异无统计学意义(<i>P</i>&gt;0.05);治疗后,II级组、III级组血清sCD40L水平均较治疗前显著降低(<i>P</i>均=0.001),且II级组血清sCD40L水平显著低于III级组(<i>P</i>=0.001)。该结果和Riphagen等<citation id="96" type="reference"><link href="43" rel="bibliography" /><sup>[<a class="sup">20</a>]</sup></citation>研究结果一致,进一步提示血清sCD40L水平高低一定程度上反映了患者HF程度及临床预后情况。既往有关血清NT-proBNP水平检测用于HF患者早期诊断、HF程度评估及预后评定等方面的研究较多,且绝大多数研究<citation id="97" type="reference"><link href="29" rel="bibliography" /><link href="41" rel="bibliography" /><sup>[<a class="sup">13</a>,<a class="sup">19</a>]</sup></citation>均证实血清sCD40L水平越高预示患者HF程度越严重,也预示着临床预后越差。但目前有关血清sCD40L水平与老年HF患者HF程度、预后评估及MACE发生之间的关系的研究较少。此外,本次研究还发现,治疗期间,无MACE组血清sCD40L、NT-proBNP水平均显著低于MACE组(<i>P</i>均=0.001)。</p>
                </div>
                <div class="p1">
                    <p id="69">综上所述,老年HF患者血清sCD40L、NT-proBNP水平可作为预测患者HF程度的指标,且血清sCD40L、NT-proBNP水平低预示HF程度较轻,预后较好, MACE风险较低。但目前有关血清sCD40L水平与老年HF患者发生MACE的关系研究较少,加之本次研究中统计的MACE病例数较少,故下一步有待选择更大样本容量,进行多中心前瞻性研究,更进一步明确血清sCD40L和NT-proBNP水平监测在老年HF患者HF程度诊断、预后评估和MACE预测中的应用价值,以寻找一种操作便捷、无创、有效的HF早期诊断及病情和预后评估的方法。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZSZD201705016&amp;v=MjEyMjdmWnVabUZ5bmhVYnpQUHo3UmFyRzRIOWJNcW85RVlvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3E=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>李春伟,李轶鹏,秦文艳,等.血清sCD40L联合NT-proBNP对心力衰竭的诊断及预后评估价值研究[J].中国实验诊断学,2017,21(5):816-819.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Diagnostic value of combining serum soluble ST2and interleukin-33 for heart failure patients with preserved left ventricular ejection fraction">

                                <b>[2]</b>Luo NS,Zhang HF,Liu PM,et al.Diagnostic value of combining serum soluble ST2 and interleukin-33 for heart failure patients with preserved left ventricular ejection fraction.[J].Zhonghua Xin Xue Guan Bing Za Zhi,2017,45(3):198-203.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYYY201602026&amp;v=MTkwOTQ5SFlvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhVYnpQUHpUU2Q3RzRIOWZNclk=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>刘子源,刘帅,张艳丽,等.sST2、NT-proBNP及sCD40L在急性冠脉综合征危险分层及预后评估中的临床意义[J].中西医结合心脑血管病杂志,2016,14(2):180-182.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGZ201505011&amp;v=MzA0MDBGckNVUjdxZlp1Wm1GeW5oVWJ6UFBUWE1kTEc0SDlUTXFvOUVaWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEc=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b>朱桢燕,孙建辉,柯海燕.血清胱抑素C与慢性心力衰竭的关系及临床意义[J].中国心血管病研究,2015,13(5):410-413.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Long-term prognostic implications of the ADHF/NT-pro BNP risk score in patients admitted with advanced heart failure">

                                <b>[5]</b>Scrutinio D,Guida P,Ammirati E,et al.Long-term prognostic implications of the ADHF/NT-proBNP risk score in patients admitted with advanced heart failure [J].J Heart Lung transplant,2016,35(10):1264-1267.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Serum level of apelin-13 negatively correlated with NT-proBNP in heart failure patients">

                                <b>[6]</b>Cerasela MG,Florin PA,Daniel CL,et al.Serum level of apelin-13 negatively correlated with NT-proBNP in heart failure patients[J].Revista Român de Medicin de Laborator,2016,24(4):399-412.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201604014&amp;v=MDc0MTA1NE8zenFxQnRHRnJDVVI3cWZadVptRnluaFVielBQVFhNWmJHNEg5Zk1xNDlFWUlRS0RIODR2UjRUNmo=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[7]</b>曾雪,方小丽,何扬利.血清25-(OH)D3、hsCRP及NT-proBNP与慢性心衰患者心衰程度及预后的关系[J].心血管康复医学杂志,2016,25(4):394-398.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZSZD201612017&amp;v=MTU4MDg2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVWJ6UFB6N1Jhckc0SDlmTnJZOUVZNFFLREg4NHZSNFQ=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b>杨雯婷.IMA、hsCRP、NT-proBNP及sCD40L指标在急性冠脉综合征早期诊断价值研究[J].中国实验诊断学,2016,20(12):2034-2037.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CBBD&amp;filename=0007117080329001&amp;v=MDk5NDBEUk04enhVU21EZDlTSDduM3hFOWZidm5LcmlmWmVadkZ5bnRVNzdNSWwwVFZWMjdHYks1R2RIRXI0eEhiZXNQ&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b>陈建,华琦.心力衰竭的诊断与治疗[M].北京:人民卫生出版社,2006.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJESB3DD36CF5187F242E5946C8EE10CBD11&amp;v=MTQzNDh3Njg9TmlmT2ZjRzdhcVhQcWZ3elllb0hDd283eXhSbTd6WjVUZ3pxMldjMGVjSG1NYnVlQ09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeGJ5OQ==&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>Hiroki N,Koichi F,Minoru T,et al.The response of NT-proBNP to intensified medication in advanced chronic heart failure [J].IJC Metabolic &amp; Endocrine,2016,10:24-29.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=STJD&amp;filename=STJDE70864F413D730D244187FA99E9B12C7&amp;v=MjEwNTBmQnJMVTA1dEJoeGJ5OXc2OD1Oam5CYXNhL0h0bktxL2xCWmVoN0MzODV1eFFYN2o1MVR3bVRwUnRBY01DVlI4bVlDT052RlNpV1dyN0pJRnBtYUJ1SFlmT0dRbA==&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>Besli F,Gullulu S,Sag S,et al.The relationship between serum lectin-like oxidized LDL receptor-1 levels and systolic heart failure[J].Acta Cardiol,2016,71(2):185-190.
                            </a>
                        </p>
                        <p id="27">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SWCX201618030&amp;v=MTY1NDFyQ1VSN3FmWnVabUZ5bmhVYnpQTmpySWRyRzRIOWZOcDQ5R1pJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0Y=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b>金德奎,於四军,王文启,等.静息心率与慢性心力衰竭患者血清NT-proBNP的相关性分析[J].现代生物医学进展,2016,16(18):3519-3522.
                            </a>
                        </p>
                        <p id="29">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PZXX201612031&amp;v=MDI5MTR6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVWJ6UE5UZlRkckc0SDlmTnJZOUdaWVFLREg4NHZSNFQ2ajU0TzM=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b>宋伟,黄国勇,方勇,等.血清N-端脑钠肽前体在慢性心力衰竭预后评价中的应用价值分析[J].中国循证心血管医学杂志,2016,8(12):1501-1503.
                            </a>
                        </p>
                        <p id="31">
                            <a id="bibliography_14" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJESDDFDE00F5E75ED3FEDA3601239E7D2EC&amp;v=MTcyMDljZk1hS1c1cjQ4ellaNElDUWxOekdCbW5rNStUbi9qcmhFOERMWGdSOC9zQ09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeGJ5OXc2OD1OaWZPZg==&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[14]</b>Heng Q.GW26-e2439 Based on clinical studies of plasma NT-proBNP for the diagnosis of diastolic heart failure optimal cutoff value observed[J].Journal of the American College of Cardiology,2015,66(16):C210-C211.
                            </a>
                        </p>
                        <p id="33">
                            <a id="bibliography_15" target="_blank" href="http://scholar.cnki.net/result.aspx?q=N-terminal pro-beta-type natriuretic peptide (NT-proBNP) can be considered a valuable predictor of heart rejection">

                                <b>[15]</b>Mehrdad S,Ali RB,Mehrzad R,et al.N-terminal pro-beta-type natriuretic peptide (NT-proBNP) can be considered a valuable predictor of heart rejection[J].Indian Journal of Thoracic &amp; Cardiovascular Surgery,2015,31(4):1-5.
                            </a>
                        </p>
                        <p id="35">
                            <a id="bibliography_16" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SDYY201626024&amp;v=MDEzOTJxWTlIWUlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnluaFVielBOaW5TZDdHNEg5Zk8=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[16]</b>林绍侠,刘志兵,蔡铁海,等.血清sST2联合NT-proBNP检测对心力衰竭患者预后的预测价值[J].山东医药,2016,56(26):61-62.
                            </a>
                        </p>
                        <p id="37">
                            <a id="bibliography_17" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=JYYL201712015&amp;v=MTEwMTR6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVWJ6UEx6VFNZckc0SDliTnJZOUVZWVFLREg4NHZSNFQ2ajU0TzM=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[17]</b>李曼,温冬梅,王伟佳,等.NT-proBNP水平对急性心力衰竭患者近期预后的评估价值[J].检验医学与临床,2017,14(12):1720-1722,1725.
                            </a>
                        </p>
                        <p id="39">
                            <a id="bibliography_18" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJHD&amp;filename=SJHDF68522678B755B915B78F7FF6C68DF98&amp;v=MTQ2NTNoY1dtRGgxUG5pVTJoUkdmN3JnTTdPWENPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhieTl3Njg9TmlmRGFzVytGdFRPcllsQ2JKa0lDWGxMeA==&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[18]</b>Passeri E,Rigolini R,Costa E,et al.Serum NT-proBNP Levels Are Not Related to Vitamin D Status in Young Patients with Congenital Heart Defects[J].Dis Markers,2016,2016.
                            </a>
                        </p>
                        <p id="41">
                            <a id="bibliography_19" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYYY201717068&amp;v=MDE2OTZiSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVWJ6UFB6VFNkN0c0SDliTnFJOUQ=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[19]</b>徐正云,任国珍.老年心力衰竭合并心房颤动病人血清NT-proBNP的临床意义[J].中西医结合心脑血管病杂志,2017,15(17):2157-2160.
                            </a>
                        </p>
                        <p id="43">
                            <a id="bibliography_20" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15120900225723&amp;v=MDYwMzRadEZpbmxVcmZJSVZvV2FSVT1OaWZPZmJLOUg5UE1wbzlGWnVrS0MzNDZvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZQ==&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[20]</b>Riphagen IJ,Logtenberg SJ,Groenier KH,et al.Is the association of serum sodium with mortality in patients with type 2 diabetes explained by copeptin or NT-proBNP?(ZODIAC-46).[J].Atherosclerosis,2015,242(1):179-185.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201905008" />
        <input id="dpi" type="hidden" value="300" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>


    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201905008&amp;v=MDcxNjg2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVWJ6UFBUWE1aYkc0SDlqTXFvOUZiSVFLREg4NHZSNFQ=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>


    <link href="/kxreader/Content/css/LeftDetail?v=vAscMyvIPP9NePnbGPkqJ0A5tHOvnzl65tGuRDsf9xg1" rel="stylesheet"/>

</body>
</html>

